Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MDRX - Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation


MDRX - Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation

PR Newswire

SAN DIEGO , March 26, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc., f.k.a. Allscripts Healthcare Solutions, Inc.

Investors, who purchased shares of Veradigm Inc. (NASDAQ: MDRX) prior to February 2021 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On November 22, 2023 , an investor in NASDAQ: MDRX shares filed a lawsuit against Veradigm Inc. over alleged violations of securities laws. The plaintiff alleged that the defendants between February 26, 2021 and June 13, 2023 made false and/or misleading statements and/or failed to disclose that Veradigm had overstated its historical revenues by at least $20 million , that Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over a more than two-year period, that Veradigm had artificially inflated its earnings and margins and materially misrepresented demand for Veradigm's products and services, that Veradigm had failed to maintain effective internal controls over its financial reporting, and that Veradigm had failed to comply with Generally Accepted Accounting Principles regarding appropriate revenue recognition practices.

On January 05, 2024 , an amended complaint was filed and on March 1, 2024 , the court appointed a lead plaintiff and lead counsel.

Those who purchased shares of Veradigm Inc. (NASDAQ: MDRX) prior to February 2021 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE Shareholders Foundation, Inc.

Stock Information

Company Name: Allscripts Healthcare Solutions Inc.
Stock Symbol: MDRX
Market: NASDAQ
Website: allscripts.com

Menu

MDRX MDRX Quote MDRX Short MDRX News MDRX Articles MDRX Message Board
Get MDRX Alerts

News, Short Squeeze, Breakout and More Instantly...